Lv1
78 积分 2024-11-13 加入
Geriatric screening tools predict survival outcomes in older patients with diffuse large B cell lymphoma
4小时前
待确认
Comparative analysis of the tumor microenvironment in primary CNS and testicular large B-cell lymphomas using digital image analysis and its implications for immunotherapy
1个月前
已关闭
Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial
1个月前
已完结
Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma
2个月前
已完结
The treatment of marginal zone lymphoma
3个月前
已完结
Drug development in MZL: caring for the forgotten child
3个月前
已关闭
A real-world pharmacovigilance study of tafasitamab: data mining of the US food and drug administration adverse event reporting system
3个月前
已完结
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
4个月前
已完结
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
4个月前
已完结
Real-World Outcomes with Orelabrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective Study
4个月前
已完结
皖公网安备34019202002308
